Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Altria Group Inc (MO) vs Tilray Brands Inc (TLRY) Price & Performance

Altria Group IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Tilray Brands Inc — how do they compare? Altria Group Inc trades at $65.13 (market cap $114.13B), while Tilray Brands Inc trades at $4.77 (market cap $601.34M). The key difference: Altria Group Inc is far larger — about 189.8× Tilray Brands Inc's market cap, and Altria Group Inc pays a 6.2% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

MOTLRY
Market Cap
$114.13B$601.34M
Sector
Consumer StaplesHealth
52-Week High
$74.92$21.00
52-Week Low
$54.72$3.88
Enterprise Value
$136.34B$768.47M
Dividend Yield
6.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.

MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.

Tilray Brands Inc

TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.

Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY